Shin Kong Life Insurance (SHIKON)

At present, Shin Kong Life is a transition-period life insurance credit with a large incumbent franchise in Taiwan’s life insurance market, but with clear standalone vulnerability in capital and FX/ALM from the former company. The direction of credit quality has room to improve, but the former Shin Kong Life’s end-2025 capital adequacy non-compliance and Fitch’s Rating Watch Evolving mean improvement cannot be regarded as complete. The probability of rapid change in credit quality level or direction is moderate, because FX, TIS/RBC, post-merger fair value assessment, rating actions, and Tier 2 terms could change the view over a short period.

The credit strengths are the company’s fourth-place franchise in Taiwan by 2024 total premiums, more than 7,300 sales agents, 8.99 million in-force policies, high persistency, the 2025 increase in new business CSM, the banking, securities, and asset management platform of the TS Holdings group, and a record of capital raising in domestic and overseas markets. The constraints are the former company’s history of capital deficiency and FX/ALM risk. The sequence of capital deficiency in 2023, recovery through capital reinforcement in 2024, and renewed statutory capital adequacy non-compliance at the former Shin Kong Life at end-2025 shows that the company’s capital is sensitive to markets, FX, and regulatory calculations.

By security class, senior issuer credit and Tier 2 should be separated. Under the Offering Circular, the USD Tier 2 carries a subordinated guarantee from the former Shin Kong Life and is subordinated to policyholders and senior creditors. Post-merger guarantor succession / substitution procedures are unconfirmed, and the call, interest payment, regulatory capital event, guarantor substitution, and post-merger succession provisions should be checked before investing in the individual bond.